Klaus Dugi
InvestorVenture Partner at +ND Capital
Switzerland
Writes $100K – $5M checks · typically $1.5M
About
Klaus joined +ND Capital's Lausanne office in 2021 after 18 years in the pharmaceutical industry, including over 8 years as Chief Medical Officer at Boehringer Ingelheim. He is currently CEO of Vandria.
Experience
- VandriaChief Executive Officercurrent2021 — presentLausanne, Vaud, Switzerland
- NanoDimensionVenture Partner and Chief Medical Advisorcurrent2021 — presentLausanne, Vaud, Switzerland
- AOBiome Therapeutics, Inc.Non Executive Directorcurrent2018 — presentBoston, Massachusetts, United States
- Ferring PharmaceuticalsExecutive Vice President and Chief Medical Officer2017 — 2020St. Prex, Switzerland
- Boehringer Ingelheim Limited UKManaging Director UK & Ireland2015 — 2017Bracknell, UK
- Boehringer IngelheimChief Medical Officer2010 — 2015
- Boehringer IngelheimCorporate Vice President Medical Affairs2008 — 2009
- Boehringer IngelheimVice President Therapeutic Area Metabolic Diseases2006 — 2008
- Med. Univ.Klinik. HeidelbergAttending Physician2001 — 2002
Colleagues at +ND Capital
Aditya Rajagopal
Venture Partner at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Gabriela Ecco
Principal at +ND Capital
Network3
Alison Palmer
Vice President of the General Partner at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Gabriela Ecco
Principal at +ND Capital
Investors connected to Klaus in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Klaus Dugi work?
- Klaus Dugi is Venture Partner at +ND Capital.
- What check size does Klaus Dugi write?
- Klaus Dugi typically writes checks of $100K – $5M.
Founder mafias
+ND Capital mafia2
Also came through, then founded or led a company.
Shared employers
Also worked at Ferring Pharmaceuticals5
Also worked at Boehringer Ingelheim26
Drew GonzalesInvestor at Side Door VenturesKazu NonomuraPartner, Director at RDiscoveryShinobu SuzukiScientific Advisor at RDiscoveryDhiren PatelDigital Pharma Advisor at Excelerate Health VenturesPeter FarinaExecutive in Residence at Canaan PartnersMarcel ZijpSenior Investment Manager at Brightlands Venture Partners
+ 20 more



















.jpg)
